LINDSAY GLANVILLE: Open Payments
NPI 1851601744 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,972 in 160 payments from 22 companies in 2025. Trend: 2023 $1,768 · 2024 $2,363 · 2025 $2,972
Food & beverage: $2,885Education: $87
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 31 | $707 |
| ABBVIE INC. | 27 | $517 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $374 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 25 | $264 |
| Phathom Pharmaceuticals, Inc. | 19 | $217 |
| Ardelyx, Inc. | 6 | $143 |
| Novo Nordisk Inc | 3 | $86 |
| PFIZER INC. | 4 | $83 |
| GENZYME CORPORATION | 3 | $82 |
| Ipsen Biopharmaceuticals, Inc | 3 | $80 |
Products named: TREMFYA, XIFAXAN, ENTYVIO, RINVOQ, VOQUEZNA, LINZESS, IBSRELA, DUPIXENT.
Industry payments across NY — which companies pay providers there.
